General Information of the Compound
| Compound ID |
CP0049376
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
CICLACILLIN
Show/Hide
|
||||||||||||||||||
| Synonyms |
(1-Aminocyclohexyl)penicillin
(2S,5R,6R)-6-[(1-aminocyclohexanecarbonyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-6-{[(1-aminocyclohexyl)carbonyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(1-aminocyclohexanecarboxamido)-3,3-dimethyl-7-oxo-(8CI)
6-(1-Aminocyclohexanecarboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid
6-(1-Aminocyclohexanecarboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
6-(1-Aminocyclohexanecarboxamido)penicillanic acid
6-(1-Aminocyclohexylcarboxamido)penicillanic acid
6beta-(1-aminocyclohexanecarboxamido)-2,2-dimethylpenam-3alpha-carboxylic acid
AC 98
Aminocyclohexyl penicillin
Aminocyclohexylpenicillin
Bastcillin
C-12104
Calthor
Ciclacilina
Ciclacilina [INN-Spanish]
Ciclacillin
Ciclacillin (JP15/INN)
Ciclacilline
Ciclacilline [INN-French]
Ciclacillinum
Ciclacillinum [INN-Latin]
Ciclacillum
Citosarin
Cyclacillin
Cyclacillin (USAN)
Cyclacillin [USAN]
Cyclapen
Cyclapen (TN)
Cyclapen-W
Cyclapen-W (TN)
Noblicil
Orfilina
Peamezin
Syngacillin
Ultracillin
Vastcillin
Vastcillin (TN)
Vipicil
WY 4508
WY4508
Wy-4508
Wyvital
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C15H23N3O4S
|
||||||||||||||||||
| Molecular Weight |
341.433
|
||||||||||||||||||
| Canonical SMILES |
CC1(C)S[C@@H]2[C@H](NC(=O)C3(N)CCCCC3)C(=O)N2[C@H]1C(O)=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C15H23N3O4S/c1-14(2)9(12(20)21)18-10(19)8(11(18)23-14)17-13(22)15(16)6-4-3-5-7-15/h8-9,11H,3-7,16H2,1-2H3,(H,17,22)(H,20,21)/t8-,9+,11-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
HGBLNBBNRORJKI-WCABBAIRSA-N
|
||||||||||||||||||
| CAS |
3485-14-1
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound